While research on BPC-157, particularly in United States human trials, is ongoing and has shown promising results, it is primarily available for research purposes
Sendoel A, Kohler I, Fellmann C, Lowe SW, Hengartner MO
152 Additionally, cleavage to form the active drug may not occur at a sufficient rate and with the necessary accuracy to produce localized therapeutic concentrations of the drug
Women interested in peptide therapy often ask whether BPC-157 may affect hormones, menstrual cycles, fertility, menopause symptoms, or overall hormonal balance
What makes them different is which genes are turned on, which genes are turned off, and how strongly those genes are expressed